← Open Payments lookup

MARY BOURBON: Open Payments

NPI 1023499548 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$249 in 13 payments from 8 companies in 2025. Trend: 2023 $34 · 2024 $231 · 2025 $249

Food & beverage: $249
CompanyPaymentsAmount
Alkermes, Inc.4$94
ABBVIE INC.2$37
Axsome Therapeutics, Inc.2$33
Orexo US, Inc.1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$18
Indivior Inc.1$16
Otsuka America Pharmaceutical, Inc.1$15
Vanda Pharmaceuticals Inc.1$14

Products named: VIVITROL, VRAYLAR, Auvelity, ARISTADA, Zubsolv, CAPLYTA, SUBLOCADE, REXULTI.

Industry payments across MD — which companies pay providers there.